Spectrum Pharmaceuticals Down 33.7% Since SmarTrend's Sell Recommendation
Do you know when to trade SPPI ?
SPPI | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Spectrum Pharmaceuticals (NASDAQ:SPPI) on September 25, 2009 at $6.47.
Since then, Spectrum Pharmaceuticals has returned 33.7% as of today's recent price of $4.29. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Spectrum Pharm Inc (SPPI) SPPI. Spectrum Pharm Inc (SPPI) has Short Term PowerRatings at TradingMarkets. Details on Spectrum Pharm Inc (SPPI) Short Term PowerRatings is available at This Link.
- TopoTarget advances cancer drug candidate into Phase I/II - 03/19/10
- Spectrum Pharmaceuticals (SPPI) Corporate Event Announcement Notice - 03/17/10
- Spectrum Pharmaceuticals (SPPI) Corporate Event Announcement Notice - 03/16/10
- Spectrum Pharmaceuticals to Present at the 22nd Annual Roth Capital Markets Growth Conference on Monday, March 15 - 03/11/10
- Market Watch for Spectrum Pharmaceuticals Inc. Issued by Beacon Equity - 03/02/10
- More News >>


